Formation of cowpox virus-specific cell surface antigen (CPV S-ag) was enhanced in HVJ (Sendal virus) carrier cells compared to that in parent cells. Temperature shifts from 32 to 35 to 37 °C for these carrier cultures reduced this enhancing activity, making them equivalent to parent cells. The eclipse phase and one-step growth of CPV in the carrier cells were shorter than in normal cells. Extracts of carrier cells exhibited a stimulating activity causing the temporary rise and subsequent lowering of CPV infectivity in their reactions with CPV in vitro, suggesting a cellular acceleration of CPV uncoating. The S-ag forming ability of these carrier cells did not decrease as much as that of parent cells in the presence of actinomycin D or puromycin. The results indicate that persistent infection with HVJ, especially the temperature-sensitive variant, promotes the first step of intracellular growth of CPV, resulting in enhanced formation of S-ag.
INTRODUCTION
Since the formation of poxvirus-specific cell surface antigen (S-ag) was first reported in HeLa cells (Ueda, Ito & Tagaya, I969; Ueda et al. I972) and FL cells (Miyamoto & Kato, I968, I97I) , it has also been tested by the present authors in various cells. In these tests, some cells reproducibly formed much more S-ag, but other cells did not. This suggests the dependency of S-ag forming ability on the specificity of the cell species. The competence of cells producing little S-ag was remarkably enhanced in the presence of trypsin without a significant effect on the virus adsorption or the formation of intracytoplasmic virus antigen (Tanaka & Hatano, I973) .
On the other hand, the HVJ (Haemagglutinating virus of Japan; Sendal virus) carrier cultures allowed increased multiplication of other viruses (Maeno et al. I966) or enhanced cellular repair activity (Satoh & Yamamoto, i972; Yamamoto, Morita & Satoh, I97z) . Moreover, the possibility that it is easy to establish an HVJ-carrier state with temperaturesensitive (ts) variants has been suggested recently in relation to the isolation of ts variants from the HVJ carrier cultures (Kimura et al. 1975; Morita, I975) .
Therefore, a possible effect of persistent infection with HVJ, especially ts variants, was examined here to discover whether this causes low S-ag producing cells to convert to highproducing ones. J. TANAKA, O. MORITA AND M. HATANO
METHODS
Tissue cultured cells. THEL (derived from embryonic hamster lung; Yamada & Hatano, I972 ) and VERO (Yasumura & Kawakita, I963) , and their HVJ carrier cells were cultured with Eagle's MEM (minimum essential medium) containing IO ~ or 2 ~ calf serum. Temperatures of these cultures ranged from 32 to 39 °C depending on the experimental design and were usually maintained between times at 35 °C.
Viruses. Cowpox virus (CPV), LB-R strain, was used for the poxvirus S-ag formation. VERO cells infected with CPV (2-0 p.f.u. [cell) were sonicated in the cold for 60 s at 30 W (in a Branson sonifier, U.S.A.) together with the culture medium at 24 h.p.i, and clarified by low-speed sedimentation at 4 °C. The supernatant fluids were used as virus stock and were stored at -9 ° °C until use. They were further purified and concentrated as previously described Ooklik, I962, I964), if required.
The wild type of HVJ (HVJo), Nagoya-x-6o strain, was propagated in developing chick embryos. Temperature-sensitive (ts) HVJ variant (HVJts) was extracted from the HVJ carrier THEL cells cultured at 32 °C (Morita, I975) . For this purpose, the HVJ carrier cell suspension of more than 5 x IO n cells/ml in MEM was sonicated and then clarified similarly to the CPV stock preparation. This HVJpits was also grown in developing chick embryos at 32 °C and, thereafter, designated as HVJpits-e.
Virus assay. CPV was assayed by plaque-forming ability on VERO cells. The cells were seeded in bottles (5 x 4 x 3 cm) at a density of about 5 x io 5 cells/bottle. Two or three days later, confluent cell monolayers were infected with CPV samples in serial dilutions with MEM. After adsorption for 2 h at 35 °C, the infected cells were washed once with MEM and maintained with 5 ml of MEM containing I : 5o0 anti-CPV rabbit serum. They were stained 2 days later with o.I ~ crystal violet solution dissolved in phosphate buffered saline, pH 7-2, after the removal of maintenance medium. The plaques formed were counted as p.f.u./ml. Stock viruses usually showed more than 5 x io 7 p.f.u./ml.
For the assay of HVJ, the CIU (cell infectious unit) method (Kashiwazaki, Homma & Ishida, I965) was employed. This method was chosen because of its high sensitivity which was equal to plaque assay, in contrast to the relatively laborious HVJ plaque assay in the VERO-trypsin system (Ito et al. 197o; Morita, I975) . Usually, HVJo, HVJpits and HVJpits-e showed more than 1 x io 8, I x Io ~ and 5 x IO r CIU/ml, respectively.
Detection of CPV S-and V-ag by fluorescent antibody (FA) staining. Hyperimmunized anti-CPV rabbit sera were prepared as previously described (Ueda et aL I969) . The sera useful for FA preparation showed more than I:5ooo neutralizing activity by plaque reduction. Including HVJ-FA used for the HVJ CIU assay, a general FA preparation was carried out according to a previous report (McDevitt et al. I963) .
Details of FA techniques for the detection of CPV S-and V (virus)-ag, employing cells infected in the presence or absence of cytosine arabinoside (20/zg/ml), were as previously described (Ueda et aI. 2969; Tanaka & Hatano, I973) . Ratios (~) of CPV S-or V-ag positive cells were calculated from more than 5oo cells examined.
Establishment of cell cultures persistently infected with HVJ. THEL cell monolayers in culture bottles (5 x 5 x so cm) were infected with HVJo at x'o CIU/cell and adsorbed at 35 °C for 2 h. The infected monolayers were washed with MEM and incubated with 15 ml of the culture medium at 35 °C to permit virus growth and cell death. Surviving cells were refreshed with the culture medium every 3 to 4 days and cultured for about two weeks until the formation of large colonies occurred. These colonies were trypsinized and subcultured, but a recurrent c.p.e, in these subcultures made it hard for the cells to establish a stable HVJo carrier state. A stable culture without c.p.e, was established two or three months after the HVJo infection. However, c.p.e, in the similar infection with HVJpits or HVJpits-e occurred infrequently. The infected cells could be subcultured within a shorter period, usually 3 to 4 days after the virus infection, suggesting the possibility of immediate establishment of a stable carrier state.
Both these stable carrier cultures could be maintained without c.p.e, and were proved to be persistently infected with HVJ as demonstrated by FA staining for HVJ antigen and by haemadsorption (HAD) of the cells (Yamada & Hatano, ~972) . The percentage of HAD positive cells in more than 5oo cells examined were calculated after a microscopical observation of the cells cultured on coverglass.
Preparation of intracellular CV. This was done by sonication of CPV-infected cells as with the CPV stock preparation. However, the infected cells were washed twice with MEM containing ~ : 2o0 anti-CPV serum before sonication to exclude unadsorbed or extracellular CPV and subsequently twice again with serum-free MEM.
In vitro reaction of CPV with NP4o or crude cell extracts from HVJ carrier or parent THEL cells. Highly purified CPV was reacted at 37 °C with an equal volume of NP4o (Nonidet P4o, BDH Ltd, England) diluted with MEM to investigate an artificial degradation of CPV outer membrane (Easterbrook, I966; Sarov & Joklik, I972 ) . Kinetic assay of the CPV infectivity after the reaction was carried out by plaque assay. A similar reaction in vitro using the purified CPV and crude cell extracts from parent or HVJ carrier THEL cells was performed to compare the cellular activity of both cells causing a partial or complete degradation of CPV. The crude cell extracts were prepared similarly by the sonication of both cells (4"4 x ~o 7 cells/ml in MEM) at the late logarithmic phase of cell growth, as shown in the HVJpits preparation and used without centrifuging.
RESULTS

Kinetic assay of CPV S-ag formation in THEL and VERO cells, and in their HVJ carrier cells
The results are illustrated in Fig. I . The formation of CPV S-ag in VERO cells occurred first at z h p.i. and its ratios reached 80 ~o at 8 h. In contrast, the occurrence of CPV S-ag in THEL cells was delayed for 2 h and they generally showed lower ratios during the 8-h observation period. However, when the HVJ carrier THEL cells were used, the S-ag formation occurred earlier and their ratios also increased significantly, approximating to those in VERO ceils. Similar enhancement of the CPV V-ag formation was observed in both HVJ carrier cells, but not to the same extent as the enhancement of the S-ag formation (data not presented). In the HVJ carrier VERO cells, the enhancement of both S-and V-ag formations was slight, suggesting the lower effect of persistent infection with HVJ in these S-ag high-producing cells.
Because these carrier cells have been maintained for more than 5 years since being established in our laboratory, it is possible that some high-producing THEL cells may be selectively established as the HVJ carrier cells with S-ag high-producing ability. This problem will be examined in the next section.
Re-examination of enhanced formation of CPV S-ag in newly established HVJ carrier cells
To re-examine the above problem, we tested again newly established carrier cultures with the HVJ ts variant or the wild type virus.
At first, the growth of the ts variant at 32 to 39 °C was compared to that of the wild Table 2 ). 
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Thus, Table 2 shows that these ts carrier cells cultured at 35 °C are capable of demonstrating an enhanced ability, even at the first subculture after the infection (ratio = I-2 to I-6). With further passaging, their abilities became almost equivalent to that in the old carrier cells (THEL-HVJ; ratio = z.o). This seems to prove that the enhanced ability of HVJ carrier cells is not due to a selective carrier establishment of high-producing THEL cells with HVJ as described in the above section. In the case of HVJo carrier cultures, however, their abilities were decreased rather than enhanced at Ioth subcultures (ratios = o.7) and first enhanced at more advanced subcultures (2oth subcultures).
In order to understand why this difference occurred between HVJts and HVJo carrier state, the culture temperature of all these carrier cells was shifted up to 37 °C for 3 days and their HAD were then examined. After this upward temperature shift, the HVJo carrier cells at Ioth subcultures still maintained HAD ratios of more than 9o ~, while the ratios in other carrier cells were less than I-O ~, except for an intermediate value of about 50 in the HVJo carrier cells but only at 2oth subcultures. Thus, the HVJo carrier cells, in which more than half of the amount of intracellular viruses came to be occupied by ts variant, appeared to be the first to express their enhanced abilities.
Relationship between culture temperature of carrier cells and CPV S-ag forming ability
To clarify the role of HVJts variant in CPV S-ag formation, the S-ag forming ability of respective HVJ carrier cells was examined again after the 3-day temperature shift of cell culture to 32 or 37 °C. As shown in Table I , 32 °C is a permissive temperature for ts variant and 37 °C is a non-permissive one.
When the cell culture and the CPV infection were performed at the permissive 32 °C, all these carrier cells clearly demonstrated the enhancement of S-ag formation with ratios of I. 9 to 2. 7 (Table 3) . However, if the experiments were performed at the non-permissive 37 °C, their S-ag formation decreased significantly and became similar to that of the parent cells. In this case, neither the ability of parent THEL nor that of the control VERO cells was affected by these temperature shifts.
HAD of these four carrier cells cultured at 32 °C was more than 9 ° ~, showing their stable HVJ carrier states. However, the cultures at 37 °C for 3 days made the HAD of THEL(HVJo)-38 cells decrease to 45 ~, while the other three carrier cells decreased less than I.O ~. This means that three carrier cells are the ts carrier state, indicating that the formation of haemagglutinin in these carrier cells is temperature-sensitive (Nagata et aL Table 2 . From these results, it is clear that the main function of HVJts may be as an enhancing mechanism in the CPV S-ag formation of these HVJ carrier cells.
CPV adsorption and its intraeellular growth on HVJ carrier cells
The possibility that the enhancement of CPV S-ag formation might be due to increased CPV adsorption on the HVJ carrier cells should be excluded here to make the above enhancing mechanism more distinct. This problem was investigated from an assay of both extracellular unadsorbed and intracellular penetrated CPV.
Ratios of adsorbed CPV calculated from unadsorbed virus assay are shown in Table 4 . Differences between these calculated CPV adsorptions were negligible among respective cells in spite of the origin of the cells. Only VERO cells expressed a significantly high CPV adsorption.
Following the above experiments, intracellular CPV was allowed to penetrate and its growth was assayed. In this experiment, it seemed to be more important to determine when cellular virus uncoating starts and when the subsequent eclipse phase and one-step initial growth occur in these HVJ carrier cells, rather than determining the amount of intracellularly penetrated CPV. As seen in Fig. 2 , the infectious CPV adsorbed on to and penetrated into the S-ag low-producing THEL cells was accumulated gradually until 2 h p.i. Then the infectivity slowly decreased from 3 h onwards, indicating the initiation of the eclipse phase. 
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Relatively high infectivity values were still maintained up to 6 h without an occurrence of one-step initial growth. In contrast, the lowering of infectivity within a shorter period (1-o to ~.5 h) and the one-step initial growth of CPV at 6 h were observed in the highproducing VERO cells. The patterns in respective HVJts carrier cells generally resembled those in VERO cells but with a slight difference. In this case, the HVJo carrier cells (THEL(HVJo)-3o), which had been observed to be the intermediate ts carrier state, as shown in Tables 2 and 3 , gave the pattern closest to that in THEL cells, except in the initiation of one-step growth.
Comparative degradation of CPV with detergent: NP4o or crude cell extracts in vitro
As the CPV uncoating process came up in examining the problem of enhanced S-ag formation, an artificial degradation of CPV in vitro was investigated. NP4o was reacted with highly purified CPV at 37 °C, as shown in Fig. 3 .
When a relatively high concentration of NP4o was used in the reaction, the CPV infectivity rapidly decreased to less than r-o ~. However, the reaction with an optimal concentration of NP4o (o.oI to o.oo~ ~) made the CPV infectivity rise early and decrease later. The peak of infectivity rise was observed at IO rain after the reaction. The meaning of this early rise of CPV infectivity in the in vitro reaction is unknown. However, it may possibly be due to a partial degradation of CPV outer membrane, which enables the CPV to adsorb on to the sensitive assay cells (VERO cells) more easily and respond to the cellular uncoating activities more rapidly, as suggested in a previous report (Easterbrook, I966 ) .
Similar in vitro experiments were performed using crude cell extracts instead of NP4o, as shown in Table 5 . The CPV infectivity with these cell extracts showed an early rise and gradual decrease, similar to those reacted with NP4o. Generally, earlier infectivity rises were reproducible in the reactions with ts carrier or VERO cell extracts. However, these 
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volume of cell extracts for indicated min; HAD positive cells cultured at infectivity alterations in the reaction with THEL(HVJo)-13 cell extracts were not significantly different from those in the reaction with parent cell extracts. The results with these HVJo carrier cell extracts seemed to correspond reasonably with the incomplete and unstable ts carrier state and the lack of cellular enhanced ability for CPV S-ag formation in these cells, as shown in Table 2 . Furthermore, in the case of the reaction with ts carrier cell extracts prepared from the cells cultured at 37 to 39 °C instead of 32 to 35 °C, the above ts-unique t + : S-antigen positive; -: S-antigen negative. Observation of S-antigen infection.
was made at 8 h after CPV pattern disappeared and approximated to that of the parent cell extracts (data not presented). The evidence of the ts carrier state again suggests an important role of ts variant in the concomitant promotion of the first stage of CPV uncoating with the enhanced formation of S-ag.
Effect of actinomycin D or puromycin on CPV S-ag formation in both HVJ carrier and parent cells
The present phenomenon of enhancement would appear very reasonable if the HVJ carrier cells could be shown to synthesize early mRNA and protein coded by the CPV genome more effectively, in addition to a promotion of cellular activity causing the CPV uncoating observed in Fig. 2 and Table 5 . Therefore, the inhibitory effect of actinomycin D (Schwarz]Mann, Germany) or puromycin (Nutritional Biochem. Corp., U.S.A.) on CPV S-ag formation was examined in both carrier and parent cells. Concentration of actinomycin D or puromycin employed here was first determined to be enough to inhibit about 90 ~ of cellular mRNA or protein synthesis without significant changes in cellular morphology up to at least 8 h in THEL cells.
From the data in Table 6 , it is clear that the CPV S-ag of VERO cells represents early intracellular proteins produced until 2 h following the coding by early mRNA of CPV synthesized within I h.p.i. In contrast, the synthesis of both early mRNA(s) and protein(s) required for S-ag formation in THEL ceils was significantly inhibited for about 4 and z h, respectively, by actinomycin D and puromycin, when compared to those in VERO cells. However, in the case of HVJ carrier THEL cells, inhibition by the two drugs occurred for only I h and was not as great as that in parent THEL cells. These results signify that the HVJ carrier cells generally have the more active mRNA and protein synthesis required for early CPV S-ag formation and approximate most closely to the S-ag high-producing VERO cells.
DISCUSSION
Our present work indicates a second way to enhance CPV S-ag formation in lowproducing cells in addition to the trypsin effect (Tanaka & Hatano, 1973) . Persistent infection with HVJ, especially the ts variant, was very effective for this purpose.
An easy and rapid establishment of the stable carrier state with the ts variant resulted in an immediate occurrence of cellular enhanced ability for the CPV S-ag formation. However, the case using the wild type (HVJo) was more complicated. The HVJo carrier state for 2o passages appeared to be a stable one which lacked c.p.e., but it did not show the above ability found in the ts carrier state. When the intermediate HVJo carrier state in 2o to 4o passages became the stable one after further subcultures, more than 9o ~ of the intracellular virus was found to be the ts variant instead of HVJo. Similar evidence was observed in the case of HVJo infection of HeLa cells (Morita, I975) . The stable ts carrier cells derived from the HVJo infection could show as strongly enhanced capacity as that in those originated from the ts variant infection. It should be made clear that there is the possibility of the existence of a few ts variants in the original HVJo and their subsequent selection to the stable ts carrier cells during long subcultures. Moreover, the true mechanism which causes the difference between rapid carrier establishment with HVJ ts variant and a retarded one with HVJo is also unknown at present. Additionally, the reason why the HVJo carrier cells cannot exhibit such a strong cellular ability as that of the stable ts carrier cells still remains obscure. It may be related to a difference of interfering activity between HVJo and ts variant, as suggested in our previous report (Morita & Hatano, 1974) .
Concerning the intracellular growth of poxvirus, it is now believed that the first step of virus uncoating is a removal or degradation of virus outer membrane by the action of intracellular enzymes, for example lysosomal enzymes, pre-existing in the cells (Joklik, I968) . Artificial degradation of CPV in vitro using the crude cell extracts as total cellular enzymes caused a significant temporary rise of CPV infectivity at an early stage of the reaction. This appears to suggest partial degradation of the CPV outer membrane. Morphology of this partial degradation of poxvirus outer membrane has already been shown by the combined reaction with NP4o and 2-mercaptoethanol (Easterbrook, I966) or in the virus-infected cells (Sarov & Joklik, I972) , though the early alteration of virus infectivity as observed by us was not described. The reaction with HVJ carrier cell extracts was sufficient to show that the CPV infectivity altered, as described above, at a faster rate than with parent cell extracts. This seems to correspond reasonably with more rapid and marked lowering of infectivity of intracellular CPV infected to the carrier cells (Fig. I) . The CPV, thus reacted in vitro, was shown to be capable of maintaining its enhanced S-ag forming ability parallel to infectivity alteration. However, the CPV reacted with HVJ or neuraminidase (derived from Clostridium welchii) equivalent to intracellular virus activity in the carrier cells did not exhibit the same changes in S-ag forming ability or infectivity (data not presented). This means that neither HVJ itself nor neuraminidase is the intracellular factor responsible for our present problem. In addition, the different inhibitory effects of actinomycin D or puromycin on the S-ag formation also suggest the different cellular functions between the carrier and the parent cells.
As another possible mechanism causing the increased infectivity of CPV in vitro, the effect of increased numbers of virus particles arising from the dispersion of aggregated CPV should not be excluded. In order to avoid these dispersion effects of poxvirus (Gifford & Klapper, I967, I969; Kim, Dalton & Sharp, I969), we always employed a CPV sample sonicated again just before use. However, our present results may be caused by a concomitant effect of the first dispersion of CPV particles due to intracellular enzymes in the extracts with the next degradation of CPV outer membrane. Therefore, the next problem to solve is the necessary analysis of the first uncoating stage using labelled virus (Joklik, I962, I964) and studies of cellular factors promoting the first uncoating in the HVJ carrier cells.
